药品注册申请号：011664
申请类型：NDA (新药申请)
申请人：MERCK
申请人全名：MERCK AND CO INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 DECADRON DEXAMETHASONE TABLET;ORAL 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None 1958/10/30 Approved Prior to Jan 1, 1982 Discontinued
002 DECADRON DEXAMETHASONE TABLET;ORAL 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None Approved Prior to Jan 1, 1982 Discontinued
003 DECADRON DEXAMETHASONE TABLET;ORAL 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None Approved Prior to Jan 1, 1982 Discontinued
004 DECADRON DEXAMETHASONE TABLET;ORAL 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None Approved Prior to Jan 1, 1982 Discontinued
005 DECADRON DEXAMETHASONE TABLET;ORAL 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None Approved Prior to Jan 1, 1982 Discontinued
006 DECADRON DEXAMETHASONE TABLET;ORAL 6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None 1982/07/30 Discontinued
批准日期，申请提交历史，通知信，药品说明书，审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级；罕用药状态通知信、审评文件、说明书、包装标签备注
2019/05/08 SUPPL-64（补充） Approval Labeling STANDARD
2018/04/23 SUPPL-65（补充） Approval Labeling STANDARD
2016/07/29 SUPPL-63（补充） Approval Labeling STANDARD
2004/05/17 SUPPL-62（补充） Approval Labeling STANDARD
2002/06/25 SUPPL-60（补充） Approval Manufacturing (CMC) PRIORITY
1999/02/19 SUPPL-58（补充） Approval Manufacturing (CMC) PRIORITY
1998/05/14 SUPPL-55（补充） Approval Manufacturing (CMC) PRIORITY
1998/02/26 SUPPL-57（补充） Approval Manufacturing (CMC) PRIORITY
1996/03/01 SUPPL-53（补充） Approval Manufacturing (CMC) PRIORITY
1993/08/25 SUPPL-50（补充） Approval Labeling STANDARD
1989/05/16 SUPPL-44（补充） Approval Labeling
1988/05/03 SUPPL-47（补充） Approval Manufacturing (CMC) PRIORITY
1985/11/26 SUPPL-45（补充） Approval Labeling
1984/05/03 SUPPL-41（补充） Approval Manufacturing (CMC) PRIORITY
1983/05/11 SUPPL-43（补充） Approval Manufacturing (CMC) PRIORITY
1983/03/22 SUPPL-42（补充） Approval Manufacturing (CMC) PRIORITY
1982/07/30 SUPPL-36（补充） Approval Labeling
1982/07/30 SUPPL-21（补充） Approval Manufacturing (CMC) PRIORITY
1982/02/10 SUPPL-37（补充） Approval Manufacturing (CMC) PRIORITY
1981/04/01 SUPPL-38（补充） Approval Labeling
1980/04/23 SUPPL-35（补充） Approval Manufacturing (CMC) PRIORITY
1980/02/05 SUPPL-32（补充） Approval Manufacturing (CMC) PRIORITY
1980/02/04 SUPPL-34（补充） Approval Labeling
1980/02/04 SUPPL-33（补充） Approval Labeling
1979/10/26 SUPPL-26（补充） Approval Manufacturing (CMC) PRIORITY
1979/09/24 SUPPL-30（补充） Approval Manufacturing (CMC) PRIORITY
1979/08/15 SUPPL-31（补充） Approval Labeling
1979/07/26 SUPPL-29（补充） Approval Labeling
1979/07/26 SUPPL-28（补充） Approval Labeling
1979/07/26 SUPPL-27（补充） Approval Labeling
1979/07/26 SUPPL-24（补充） Approval Labeling
1978/10/11 SUPPL-25（补充） Approval Manufacturing (CMC) PRIORITY
1958/10/30 ORIG-1（原始申请） Approval Type 1 - New Molecular Entity PRIORITY
与本品相关的专利信息（来自FDA橙皮书Orange Book）
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
无
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
无
与本品治疗等效的药品
本品无治疗等效药品
更多信息
药品NDC数据与药品包装、标签说明书
参考引用1
参考引用2
©2006-2024 DrugFuture->U.S. FDA Drugs Database